Jensen, J. K., Zobel, E. H., Zobel, E. H., Scholten, B. J. v., Scholten, B. J. v., Curovic, V. R., . . . Ripa, R. S. (2021). Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial. Frontiers Media S.A.
Cita Chicago Style (17a ed.)Jensen, Jacob K., et al. Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial. Frontiers Media S.A, 2021.
Cita MLA (8a ed.)Jensen, Jacob K., et al. Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial. Frontiers Media S.A, 2021.